Related Experiment Video
Updated: Aug 17, 2025

12:01
Quantification and Size-profiling of Extracellular Vesicles Using Tunable Resistive Pulse Sensing
Published on: October 19, 2014
19.4K
Identifying the Phenotypes of Tumor-Derived Extracellular Vesicles Using Size-Coded Affinity Microbeads.
Jiacheng Wu1, Zhun Lin1, Zhengyu Zou2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
Journal of the American Chemical Society
|December 17, 2022
Summary
This study presents a novel method for highly sensitive tumor-derived extracellular vesicle (tEV) phenotyping using size-coded microbeads and microfluidics. This approach enables rapid, simultaneous detection of multiple tEV biomarkers for improved cancer diagnosis and personalized treatment.
Area of Science:
- Biotechnology
- Nanotechnology
- Cancer Research
Background:
- Tumor-derived extracellular vesicles (tEVs) are promising biomarkers for cancer diagnosis and treatment.
- Challenges in tEV analysis include high heterogeneity, low biomarker expression, and spectral overlap limiting multiplex detection.
- Existing methods struggle with rapid and sensitive identification of diverse tEV phenotypes.
Purpose of the Study:
- To develop a highly sensitive method for tEV phenotyping.
- To enable rapid and simultaneous detection of multiple tEV biomarkers.
- To overcome limitations of spectral overlap in multiplex biomarker analysis.
Main Methods:
- Utilized size-coded microbeads functionalized with hairpin probes for aptamer binding to tEV biomarkers.
- Designed a microfluidic chip with spacer arrays to segregate microbeads by size, generating location-specific signals.
- Employed in situ rolling cyclic amplification (RCA) for signal amplification and fluorescence spectroscopy for detection.
Main Results:
- Achieved highly sensitive tEV phenotyping with simultaneous detection of six distinct tEV phenotypes.
- Demonstrated multiplex analysis without spectral overlap limitations.
- Showcased the platform's programmability for detecting various tEV phenotype substitutions.
Conclusions:
- The developed method offers a sensitive and rapid approach for tEV phenotyping.
- This strategy provides a new avenue for precise cancer diagnosis and personalized treatment.
- The microfluidic sensing platform is adaptable for diverse biomarker detection in clinical cohorts.

